XHKG1497
Market cap600mUSD
Jan 08, Last price
7.80HKD
1D
-1.27%
1Q
-41.96%
IPO
-13.33%
Name
Xiamen Yan Palace Bird's Nest Industry Co Ltd
Chart & Performance
P/E
21.58
P/S
2.21
EPS
0.34
Div Yield, %
3.47%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1.96b
-2.36%
Net income
201m
+4.89%
CFO
123m
-65.27%
Dividend
May 23, 20240.23626 HKD/sh
Profile
Xiamen Yan Palace Bird's Nest Industry Co., Ltd. engages in the development, production, and marketing of edible bird's nest (EBN) products in the People's Republic of China. It operates through five segments: Direct Sales to Online Customers, Direct Sales to Offline Customers, Sales to Offline Distributors, Direct Sales to E-commerce Platform, and Sales to Online Distributors. The company offers One Nest, a bowl-shape-canned EBN product series for the lifestyle of beauty and wellness; Freshly Stewed Bird's Nest, a bottle-canned EBN product series; Crystal Sugar Bird's Nest, a bottle-canned crystal sugar flavored EBN product series; and dried EBN products. It also provides EBN+ products under the One Nest Vitality, Crystal Sugar Bird's Nest with Ginseng, and Little Blue Bottle names; and +EBN products, including food products, such as EBN porridge, EBN zongzi, and various EBN beverages, as well as a range of EBN skincare products. The company offers its products through stores, as well as online. Xiamen Yan Palace Bird's Nest Industry Co., Ltd. was formerly known as Xiamen Yan Palace Bioengineering Co., Ltd. and changed its name to Xiamen Yan Palace Bird's Nest Industry Co., Ltd. in November 2023. The company was founded in 1997 and is headquartered in Xiamen, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 1,964,237 -2.36% | 2,011,715 10.76% | ||
Cost of revenue | 1,718,494 | 1,660,304 | ||
Unusual Expense (Income) | ||||
NOPBT | 245,743 | 351,411 | ||
NOPBT Margin | 12.51% | 17.47% | ||
Operating Taxes | 61,738 | 68,247 | ||
Tax Rate | 25.12% | 19.42% | ||
NOPAT | 184,005 | 283,164 | ||
Net income | 201,218 4.89% | 191,840 14.63% | ||
Dividends | (160,000) | (93,030) | ||
Dividend yield | 4.16% | |||
Proceeds from repurchase of equity | 283,029 | |||
BB yield | -7.36% | |||
| Debt | ||||
Debt current | 26,391 | 17,579 | ||
Long-term debt | 248,965 | 23,911 | ||
Deferred revenue | ||||
Other long-term liabilities | 1,383 | |||
Net debt | (261,737) | (363,567) | ||
| Cash flow | ||||
Cash from operating activities | 123,351 | 355,217 | ||
CAPEX | (24,351) | (26,139) | ||
Cash from investing activities | (17,418) | (25,611) | ||
Cash from financing activities | 81,999 | (119,215) | ||
FCF | (13,048) | 328,225 | ||
| Balance | ||||
Cash | 537,093 | 395,674 | ||
Long term investments | 9,382 | |||
Excess cash | 438,881 | 304,470 | ||
Stockholders' equity | 290,422 | 666,661 | ||
Invested Capital | 644,183 | 212,933 | ||
ROIC | 42.94% | 115.27% | ||
ROCE | 26.25% | 67.63% | ||
| EV | ||||
Common stock shares outstanding | 427,178 | 85,058 | ||
Price | 9.00 | |||
Market cap | 3,844,602 | |||
EV | 3,612,874 | |||
EBITDA | 286,560 | 394,254 | ||
EV/EBITDA | 12.61 | |||
Interest | 2,919 | 1,636 | ||
Interest/NOPBT | 1.19% | 0.47% | ||